Adipose tissue, inflammation, and cardiovascular disease
- PMID: 15890981
- DOI: 10.1161/01.RES.0000163635.62927.34
Adipose tissue, inflammation, and cardiovascular disease
Abstract
Mounting evidence highlights the role of adipose tissue in the development of a systemic inflammatory state that contributes to obesity-associated vasculopathy and cardiovascular risk. Circulating mediators of inflammation participate in the mechanisms of vascular insult and atheromatous change, and many of these inflammatory proteins are secreted directly from adipocytes and adipose tissue-derived macrophages. Several factors linking obesity with an increased cardiovascular risk have been identified. The adipocyte-specific secretory protein adiponectin is a particularly promising candidate in this context. Its levels are decreased in obesity. Adiponectin may mediate some of its demonstrated cardioprotective effects through its anti-inflammatory properties. In addition to decreased expression of beneficial adipokines, secretion of a host of inflammatory factors from visceral adipose tissue may contribute to the increased cardiovascular risk associated with obesity. The cardioprotective effects of many of the most popular drug regimens corroborate these conclusions, demonstrating that along with improvements in other therapeutic end points, they mediate improvements in systemic inflammation. In some cases, these improvements are attributable to direct suppression of inflammatory signaling in adipocytes. The targeted suppression of various proinflammatory cascades in adipocytes specifically represents an exciting new therapeutic opportunity for the cardiovascular disease area.
Comment in
-
Fenofibrate, statins, and inflammation.Circ Res. 2006 Mar 17;98(5):e49. doi: 10.1161/01.RES.0000214332.63952.4e. Circ Res. 2006. PMID: 16543503 No abstract available.
Similar articles
-
Adipose tissue inflammation in obesity and metabolic syndrome.Discov Med. 2009 Aug;8(41):55-60. Discov Med. 2009. PMID: 19788868
-
Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome.Mol Cell Endocrinol. 2010 Jan 15;314(1):1-16. doi: 10.1016/j.mce.2009.07.031. Epub 2009 Aug 12. Mol Cell Endocrinol. 2010. PMID: 19682539 Review.
-
Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.Clin Sci (Lond). 2008 Feb;114(4):275-88. doi: 10.1042/CS20070196. Clin Sci (Lond). 2008. PMID: 18194136 Review.
-
Recent advances in the relationship between obesity, inflammation, and insulin resistance.Eur Cytokine Netw. 2006 Mar;17(1):4-12. Eur Cytokine Netw. 2006. PMID: 16613757 Review.
-
The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.J Am Soc Nephrol. 2004 Nov;15(11):2792-800. doi: 10.1097/01.ASN.0000141966.69934.21. J Am Soc Nephrol. 2004. PMID: 15504932 Review.
Cited by
-
Targeting NLRP3 signaling reduces myocarditis-induced arrhythmogenesis and cardiac remodeling.J Biomed Sci. 2024 Apr 22;31(1):42. doi: 10.1186/s12929-024-01032-7. J Biomed Sci. 2024. PMID: 38650023 Free PMC article.
-
Association between periodontal disease and pericardial adipose tissue in patients with cardiovascular disease.Am Heart J Plus. 2023 May 6;30:100298. doi: 10.1016/j.ahjo.2023.100298. eCollection 2023 Jun. Am Heart J Plus. 2023. PMID: 38510923 Free PMC article.
-
Characterization of metabolic alterations in the lean metabolically unhealthy alpha defensin transgenic mice.iScience. 2024 Jan 12;27(2):108802. doi: 10.1016/j.isci.2024.108802. eCollection 2024 Feb 16. iScience. 2024. PMID: 38318380 Free PMC article.
-
The association between adipokines and pulmonary diseases: a mendelian randomization study.BMC Pulm Med. 2024 Jan 23;24(1):50. doi: 10.1186/s12890-024-02863-8. BMC Pulm Med. 2024. PMID: 38263093 Free PMC article.
-
Association between abdominal adiposity and clinical outcomes in patients with acute ischemic stroke.PLoS One. 2024 Jan 11;19(1):e0296833. doi: 10.1371/journal.pone.0296833. eCollection 2024. PLoS One. 2024. PMID: 38206990 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical